Coronavirus: ASX pharmacy networks report surge in demand

Australian pharmacies are looking to follow in the footsteps of supermarkets, with panic-buying due to the coronavirus crisis causing a surge in demand.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX pharmacy networks are looking to follow in the footsteps of supermarkets, with panic-buying due to the coronavirus crisis causing a surge in demand. In an update to the market, Australian Pharmaceutical Industries Ltd (ASX: API) reported that the company has experienced unprecedented demand in the month to date.

Here's a closer look at how pharmaceutical companies on the ASX have performed and the outlook for the sector during this bear market.

What did API report?

API is the listed owner of Priceline Pharmacy chains, with a network of nearly 500 stores across Australia. In the update, API informed the market that the company has seen demand during March surge by more than 50% as consumers stockpile medications. The COVID-19 pandemic has seen unprecedented demand for PBS (Pharmaceutical Benefit Scheme) and other medications.

Although API reported improved like-for-like sales throughout its pharmacy network, the company was unable to provide a profit guidance given the fluid nature of the pandemic. API pharmacies are likely to remain open during any shutdown given their essential role in the healthcare system.

API elaborated on the company's ability to ensure an ongoing supply of medicines during times of crisis, citing the measures and contingencies it put in place during the bushfire emergency to ensure the delivery of vital medications to fire-affected areas.

The API share price is currently trading more than 4% higher today.

How have other pharmacy networks performed?

Sigma Healthcare Ltd (ASX: SIG) and AFT Pharmaceuticals Ltd (ASX: AFP) are 2 other notable pharmaceutical networks listed on the ASX. Both companies have reported an increased demand for product, especially for cold and influenza medications.

In order to ensure that there is an ongoing supply for medicines in the community, the government has had to intervene by placing purchase limits on pharmaceutical products. Under the restrictions, pharmacies have been instructed to dispense only 1 month's worth of prescription medicines and limit the purchase of some over-the-counter products.

Should you buy?

Pharmacies are considered an essential service and will most likely remain open for business if there is a nationwide lockdown. Although pharmaceutical companies may be experiencing a surge in demand, investors should exercise caution when selecting stocks to invest in.

For example, Sigma has reported an increase in demand, however the company recently reported a full-year loss of $12.33 million, in comparison to a profit of $36.52 million in January 2019. I think a prudent strategy would be to compile a larger watchlist of pharmaceutical and biotech companies and let positive price action dictate before making an investment decision.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »